Tirzepatide (Mounjaro) is a dual agonist targeting both GLP-1 and GIP receptors, which tends to produce greater weight loss
Accessed Apr
By reactivating your body's own signaling systems, you can build a stronger, sharper, and more resilient version of yourself
Probiotic therapy of COVID-19 patients with a combination of nine different lactobacilli strains (as daily dose), showed significant alterations in gut microbiota, partial restoration of pulmonary dysfunction as well as intestinal dysbiosis
Stronger products may be more likely to cause redness, tingling, itching, dryness, or irritation, especially if your skin barrier is already sensitive
Now we know its just as much about inflammation and environment and thats where GLP-1s, the so-called weight loss drugs, come in